Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Sexual Dysfunctions, Psychological

• Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder
• An Open-Label Study of 50 mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women With Low Testosterone and HSDD
• Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
• Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
• Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
• Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
• A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With
• Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD).
• Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
• Hypoactive Sexual Desire Disorder in Males
• Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
• Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
• Study to Investigate the Effect of AB-101 in Breast Cancer Survivors
• BP101 for Adults With Female Sexual Dysfunction
• Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
• Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
• Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
• Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men
• Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
• 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
• 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
• Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder
• Effects of Tribulus Terrestris in Postmenopausal Women With Hypoactive Sexual Desire Disorder
• Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder
• Phase 1b/2a Unblinded Study of Responses in Premenopausal Women With HSDD to Lorexys Evaluating Efficacy and Safety
• Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems
• Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder
• Lybrido for Female Sexual Dysfunction
• Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
• Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
• Testosterone Patch's Effects on the Cardiovascular System and Libido
• Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)
• A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
• A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®
• Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
• 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
• Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
• Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
• Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder
• An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
• Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder
• Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
• Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
• Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder
• Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder
• Flibanserin Versus Placebo in Premenopausal Women With HSDD
• The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.
• Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
• A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
• Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
• Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
• Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
• 24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
• 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
• Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
• Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
• Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
• Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
• Topical Alprostadil for Female Sexual Arousal Disorder
• Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
• Female Orgasmic Disorder (FOD) and Wellbutrin XL
• Testosterone in Female Hypoactive Sexual Desire Disorder
• Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido
• Zestra in Women With Mixed Sexual Dysfunction
• Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction